Cervical cancer treatment with dendritic cell therapy

Immunotherapy for cancer is considered one of the most promising areas of medicine. It is with this that the upcoming breakthrough in cancer treatment is associated. Some immunotherapy methods have already proven themselves to be effective, allowing for the suppression of the development of cancer for a long time or even curing cancer in advanced stages.

Dendritic cells (DC cells) are one of the tools used to stimulate an antitumor immune response. They are immune cells that "learn" the antigen themselves and then "train" the T cells to fight the foreign agent in the body.

Cervical cancer is the most common gynecologic cancer in the world. Interestingly, this is one of the few oncological diseases against which one can be vaccinated. Almost all cases of cancer of the cervix are associated with the human papillomavirus. Vaccines have been developed against it to protect against infection. But in most countries in the world, total vaccination of the population is not carried out, and screening programs are poorly organized, so the incidence of cervical cancer remains very high. Almost half a million new cases are reported worldwide every year.

The standard treatment methods for the disease are surgery and radiation therapy. Cytostatic chemotherapy is also widely used. New directions of drug treatment, such as targeted therapy and immunotherapy, are still not widely used for malignant tumors in the cervix.

?? To learn more about dendritic cell treatment for cervical cancer, check out our new blog article: https://bit.ly/3LovPQd

?? To get professional help in planning treatment abroad, leave an enquiry on our website: https://bit.ly/3HlssY5

#BookingHealth #сervicalcancer #dendriticcells #treatmentabroad #treatmentabroad #treatmentingermany #medicaltourism